MigraineMind research summary
TRPV1‑mediated central sensitisation: Core mechanisms of migraine chronification and novel targeted therapeutic strategies (Review).
Int J Mol Med | 2026
Laboratory / animal studySummary
Migraines are common and debilitating neurological disorders affecting many people. Central sensitisation is the main cause of their recurrent and chronic nature. Transient receptor potential vanilloid 1, or TRPV1, plays a crucial role in pain signalling. This molecule is involved in both peripheral and central pain processing. TRPV1 contributes to the initiation and maintenance of central sensitisation. This makes it a significant therapeutic target for migraine management. The review summarizes TRPV1's biological characteristics and its link to central sensitisation. It elaborates on the molecular mechanisms by which TRPV1 mediates central sensitisation. These include regulating neurotransmitter release and activating glial cells. Additionally, TRPV1 is involved in inflammatory responses and modulating synaptic plasticity. The study also discusses challenges with TRPV1-targeted strategies, such as antagonists and agonists. Lastly, it proposes future research directions for targeted clinical therapies in migraine treatment. Clinical relevance: This research highlights TRPV1 as a potential target for migraine therapies.
Key Learning Points
- Migraines are common and can significantly impact daily life, making effective management essential.
- Central sensitisation is a key factor in the recurring and chronic nature of migraines.
- The TRPV1 molecule is crucial in how pain is processed and can be targeted for migraine treatment.
- Understanding TRPV1's role in pain signalling may lead to new therapeutic strategies for migraine sufferers.
- Future research is needed to overcome challenges in developing effective TRPV1-targeted therapies.
Related migraine research topics
Original research
Read the original publication and review its full methods and findings on PubMed.
MigraineMind is an educational resource designed to complement—not replace—the original scientific literature or clinical judgement. This page is an AI-generated summary of the available paper information and may contain errors. Please consult the original publication.